Interferons as negative regulators of ILC2s in allergic lung inflammation and respiratory viral infections
Abstract Group 2 innate lymphoid cells (ILC2s), characterized by a lack of antigen receptors, have been regarded as an important component of type 2 pulmonary immunity. Analogous to Th2 cells, ILC2s are capable of releasing type 2 cytokines and amphiregulin, thus playing an essential role in a variety of diseases, such as allergic diseases and virus-induced respiratory diseases. Interferons (IFNs), an important family of cytokines with potent antiviral effects, can be triggered by microbial products, microbial exposure, and pathogen infections. Interestingly, the past few years have witnessed encouraging progress in revealing the important role of IFNs and IFN-producing cells in modulating ILC2 responses in allergic lung inflammation and respiratory viral infections. This review underscores recent progress in understanding the role of IFNs and IFN-producing cells in shaping ILC2 responses and discusses disease phenotypes, mechanisms, and therapeutic targets in the context of allergic lung inflammation and infections with viruses, including influenza virus, rhinovirus (RV), respiratory syncytial virus (RSV), and severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2)..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:101 |
|---|---|
| Enthalten in: |
Journal of molecular medicine - 101(2023), 8 vom: 06. Juli, Seite 947-959 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wang, Cui [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
Allergic lung inflammation |
|---|
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
|---|
| doi: |
10.1007/s00109-023-02345-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2144824258 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2144824258 | ||
| 003 | DE-627 | ||
| 005 | 20240118101107.0 | ||
| 007 | tu | ||
| 008 | 240118s2023 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00109-023-02345-0 |2 doi | |
| 035 | |a (DE-627)OLC2144824258 | ||
| 035 | |a (DE-He213)s00109-023-02345-0-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 570 |a 610 |q VZ |
| 084 | |a 12 |2 ssgn | ||
| 100 | 1 | |a Wang, Cui |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Interferons as negative regulators of ILC2s in allergic lung inflammation and respiratory viral infections |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
| 520 | |a Abstract Group 2 innate lymphoid cells (ILC2s), characterized by a lack of antigen receptors, have been regarded as an important component of type 2 pulmonary immunity. Analogous to Th2 cells, ILC2s are capable of releasing type 2 cytokines and amphiregulin, thus playing an essential role in a variety of diseases, such as allergic diseases and virus-induced respiratory diseases. Interferons (IFNs), an important family of cytokines with potent antiviral effects, can be triggered by microbial products, microbial exposure, and pathogen infections. Interestingly, the past few years have witnessed encouraging progress in revealing the important role of IFNs and IFN-producing cells in modulating ILC2 responses in allergic lung inflammation and respiratory viral infections. This review underscores recent progress in understanding the role of IFNs and IFN-producing cells in shaping ILC2 responses and discusses disease phenotypes, mechanisms, and therapeutic targets in the context of allergic lung inflammation and infections with viruses, including influenza virus, rhinovirus (RV), respiratory syncytial virus (RSV), and severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). | ||
| 650 | 4 | |a Interferons | |
| 650 | 4 | |a ILC2s | |
| 650 | 4 | |a Allergic lung inflammation | |
| 650 | 4 | |a Respiratory viral infection | |
| 700 | 1 | |a Du, Zhaoxiang |4 aut | |
| 700 | 1 | |a Li, Ranhui |4 aut | |
| 700 | 1 | |a Luo, Ying |4 aut | |
| 700 | 1 | |a Zhu, Cuiming |4 aut | |
| 700 | 1 | |a Ding, Nan |4 aut | |
| 700 | 1 | |a Lei, Aihua |0 (orcid)0000-0002-1498-5520 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of molecular medicine |d Springer Berlin Heidelberg, 1995 |g 101(2023), 8 vom: 06. Juli, Seite 947-959 |w (DE-627)182652114 |w (DE-600)1223802-8 |w (DE-576)045304491 |x 0946-2716 |7 nnns |
| 773 | 1 | 8 | |g volume:101 |g year:2023 |g number:8 |g day:06 |g month:07 |g pages:947-959 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s00109-023-02345-0 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a GBV_ILN_2018 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4277 | ||
| 912 | |a GBV_ILN_4305 | ||
| 951 | |a AR | ||
| 952 | |d 101 |j 2023 |e 8 |b 06 |c 07 |h 947-959 | ||